Jonathan Corren

Jonathan Corren, MD, has been a faculty member of the Departments of Medicine and Pediatrics at the David Geffen School of Medicine of the University of California, Los Angeles (UCLA) since 1991, and is actively involved in allergy and immunology education at the university. He is also medical director of a private practice in allergy/immunology and research director of a clinical research site that focuses on severe asthma, chronic rhinosinusitis, allergy immunotherapy, immunodeficiencies, and allergic skin diseases. 

Dr. Corren’s research papers regarding the use of biologic medications in severe asthma have been published in the New England Journal of Medicine, Lancet, the Journal of Allergy and Clinical Immunology, and CHEST. He is also a fellow of the American Academy of Allergy, Asthma & Immunology. 

Dr. Corren is currently project chair for a multicenter trial evaluating the immunologic and clinical effects of allergen-specific immunotherapy combined with an inhibitor of thymic stromal lymphopoietin. He previously served as director of the Allergy/Immunology Fellowship Program, chief of Clinical Services in Allergy/Immunology, and co-head of the Nasal and Sinus Disease Center at UCLA.